This profile analyzes blood and utilizes NMR fractionation technology for state-of-the-art lipid markers and independent risk factors that illuminate the clinical complexity of cardiovascular disease (CVD) as well as a patient’s genomic predisposition to cardiovascular disease. Together, these markers provide a thorough assessment of cardiovascular health status, revealing the biochemical environment and cardiogenomic risk associated with inflammation, lipid deposits, endothelial dysfunction, and clotting factors underlying cardiovascular disease.
This information is provided for informational purposes only. Never add, change, or discontinue medication or treatment without first consulting your doctor. To make an appointment with Dr. Charny, please call 310-659-3435.